• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,886.91 -416.72
( -0.54%)
Global Indices
Nasdaq
49,198.35 -53.37
(-0.11%)
Dow Jones
7,195.79 9.71
(0.14%)
Hang Seng
59,839.06 -698.30
(-1.15%)
Nikkei 225
10,332.91 11.82
(0.11%)
Forex
USD-INR
93.91 -0.14
(-0.15%)
EUR-INR
110.02 0.03
(0.03%)
GBP-INR
127.00 0.16
(0.13%)
JPY-INR
0.59 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
36.3585943
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
15.26
30.51
EPS(TTM)
Face Value()
Div & Yield %
2.33
10
0
 

ushdev international ltd
GHV Infra gains on bagging Rs 105- cr order from GHV (India)
Apr 10,2026

The contract involves construction of various infrastructural facilities aimed at expanding the capacity of the car shed at Kalwa. The project is to be executed within a period of 24 months from the date of commencement.

The order has been awarded by a domestic entity and falls under the category of a standard work order.

Notably, the transaction is classified as a related party deal. Jahidmohmed Vijapura, deemed promoter of GHV Infra Projects, is also associated with the awarding entity.

He serves as a Director and shareholder in GHV (India) and is a designated partner in JHV Commercials LLP, which holds a significant stake in GHV Infra Projects.

The company stated that the transaction is being conducted on an arm’s length basis.

GHV Infra Projects operates in the infrastructure and construction sector as an engineering, procurement, and construction (EPC) company. The firm undertakes projects across transportation infrastructure, water management, industrial development, building construction, and environment and energy sectors.

The company's consolidated net profit zoomed 391.6% to Rs 14.55 crore on 646.1% surge in revenue from operations to Rs 137.73 crore in Q3 FY26 over Q3 FY25.